Inventor · disambiguated record
John M. Mccall
Also filed as: MCCALL JOHN · MCCALL JOHN M · MCCALL JOHN MICHAEL · MCCALL JR JOHN M
103 granted patents·25 pending applications·897 citations·filing 1975–2025
99Inventor score
Files withUPJOHN CO44REVERAGEN BIOPHARMA INC19MCCALL JOHN M13IMAGO BIOSCIENCES INC11BIOENERGENIX LLC10
Top patents by PatentIndex Score
128 records- 0195US11155522B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2020·Granted Oct 26, 2021·4 cites·41 claims
- 0295US10519118B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2018·Granted Dec 31, 2019·8 cites·22 claims
- 0395US4251526A2-Benzothiepins and compositions and methods of use thereforeMCCALL JOHN M·Filed 1979·Granted Feb 17, 1981·40 cites·6 claims
- 0495US4159331AAntihypertensive 4-aminoquinolinesUPJOHN CO·Filed 1978·Granted Jun 26, 1979·35 cites·13 claims
- 0594US11471471B2Aqueous oral pharmaceutical suspension compositionsREVERAGEN BIOPHARMA INC·Filed 2022·Granted Oct 18, 2022·3 cites·21 claims
- 0694US11382922B2Aqueous oral pharmaceutical suspension compositionsREVERAGEN BIOPHARMA INC·Filed 2020·Granted Jul 12, 2022·4 cites·26 claims
- 0794US10882835B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 5, 2021·6 cites·14 claims
- 0894US4167567AAntihypertensive 4-aminoquinolinesUPJOHN CO·Filed 1978·Granted Sep 11, 1979·28 cites·39 claims
- 0993US12187682B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2023·Granted Jan 7, 2025·1 cites·9 claims
- 1093US11724989B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2021·Granted Aug 15, 2023·2 cites·23 claims
- 1193US11230534B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 25, 2022·4 cites·10 claims
- 1293US10799514B2Non-hormonal steroid modulators of NF-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2016·Granted Oct 13, 2020·6 cites·18 claims
- 1393US10214492B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2017·Granted Feb 26, 2019·6 cites·5 claims
- 1493US9981922B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2016·Granted May 29, 2018·11 cites·9 claims
- 1593US4771042AInhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragmentsUPJOHN CO·Filed 1986·Granted Sep 13, 1988·87 cites·9 claims
- 1692US11292767B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2018·Granted Apr 5, 2022·5 cites·31 claims
- 1792US10857161B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2018·Granted Dec 8, 2020·6 cites·21 claims
- 1892US10206933B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2017·Granted Feb 19, 2019·7 cites·14 claims
- 1992US10202350B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2016·Granted Feb 12, 2019·6 cites·39 claims
- 2092US9649320B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2016·Granted May 16, 2017·8 cites·3 claims
- 2192US8207151B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2009·Granted Jun 26, 2012·13 cites·2 claims
- 2292US5120843APharmaceutically active aminesUPJOHN CO·Filed 1989·Granted Jun 9, 1992·44 cites·10 claims
- 2392US4166853AAntihypertensive 7-trifluoromethyl-4-aminoquinolonesUPJOHN CO·Filed 1978·Granted Sep 4, 1979·21 cites·30 claims
- 2491US12201639B2Aqueous oral pharmaceutical suspension compositionsREVERAGEN BIOPHARMA INC·Filed 2022·Granted Jan 21, 2025·1 cites·14 claims
- 2591US11479541B1Acid addition salts, compositions, and methods of treating thereofPIONEURA CORP·Filed 2022·Granted Oct 25, 2022·3 cites·4 claims
- 2691US8519148B2Synthesis of chirally purified substituted benzothiazole diaminesRAJE PRASAD·Filed 2008·Granted Aug 27, 2013·12 cites·83 claims
- 2791US8334279B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2011·Granted Dec 18, 2012·10 cites·11 claims
- 2891US5380839APhenylpiperazinyl steroidsUPJOHN CO·Filed 1992·Granted Jan 10, 1995·54 cites·17 claims
- 2991US4329459ATetrahydrobenzopyran derivativesUPJOHN CO·Filed 1980·Granted May 11, 1982·25 cites·16 claims
- 3090US10370346B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2017·Granted Aug 6, 2019·7 cites·48 claims
- 3190US9790195B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2014·Granted Oct 17, 2017·10 cites·58 claims
- 3290US9434758B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2014·Granted Sep 6, 2016·8 cites·2 claims
- 3389US9198921B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2011·Granted Dec 1, 2015·11 cites·48 claims
- 3489US4287338ASulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner saltsUPJOHN CO·Filed 1980·Granted Sep 1, 1981·21 cites·1 claims
- 3588US11833159B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2020·Granted Dec 5, 2023·1 cites·12 claims
- 3688US11655226B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2020·Granted May 23, 2023·1 cites·19 claims
- 3788US8673887B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseVALIDUS GENETICS·Filed 2012·Granted Mar 18, 2014·10 cites·4 claims
- 3887US7259266B2Benzopyran compounds useful for treating inflammatory conditionsPHARMACIA CORP·Filed 2004·Granted Aug 21, 2007·38 cites·1 claims
- 3987US4556656A2-BenzoxepinsUPJOHN CO·Filed 1979·Granted Dec 3, 1985·15 cites·122 claims
- 4087US2025257039A1Mct4 inhibitors for treating diseaseVETTORE LLC·Filed 2024·Application pending·0 cites
- 4187US2024285650A1NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASEREVERAGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 4286US11690853B2Non-hormonal steroid modulators of NF-κβ for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2020·Granted Jul 4, 2023·1 cites·13 claims
- 4386US10179774B2Synthesis of chirally purified substituted benzothiazole diaminesKNOPP BIOSCIENCES LLC·Filed 2016·Granted Jan 15, 2019·3 cites·36 claims
- 4486US8916560B2Heterocyclic compounds for the inhibition of PASKMCCALL JOHN M·Filed 2012·Granted Dec 23, 2014·6 cites·3 claims
- 4585US4247553AMethods of treating psychosisUPJOHN CO·Filed 1979·Granted Jan 27, 1981·13 cites·13 claims
- 4685US4153612A2-BenzoxepinsUPJOHN CO·Filed 1977·Granted May 8, 1979·22 cites·5 claims
- 4784US11390590B2Methods and processes for the preparation of KDM1A inhibitorsIMAGO BIOSCIENCES INC·Filed 2017·Granted Jul 19, 2022·3 cites·28 claims
- 4884US9868708B2Heterocyclic compounds for the inhibition of PASKBIOENERGENIX LLC·Filed 2015·Granted Jan 16, 2018·3 cites·4 claims
- 4984US9193693B2Heterocyclic compounds for the inhibition of PASKBIOENERGENIX LLC·Filed 2014·Granted Nov 24, 2015·4 cites·11 claims
- 5084US4179510AMethods of treating psychosisUPJOHN CO·Filed 1977·Granted Dec 18, 1979·16 cites·16 claims
Showing the top 50 of 128 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →